Who
David Patience
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, TriSalus Life Sciences; Chief Financial Officer, Accelerate Diagnostics.
In numbers
- Trades disclosed
- 56
- Buys
- 2
- Sells
- 13
- Bought
- $64K
- Sold
- $24K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 1 Apr 2023
- Last trade
- 1 Jul 2026
- Last filed
- 6 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 6 Jul 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code F | $65K14,650 at $4.46 | filing |
| 1 Jul 2026filed 6 Jul 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code F | $65K14,650 at $4.46 | filing |
| 15 May 2026filed 18 May 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Bought | $17K7,100 at $2.43 | filing |
| 15 May 2026filed 18 May 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Bought | $17K7,100 at $2.43 | filing |
| 23 Feb 2026filed 23 Feb 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Bought | $15K3,657 at $4.10 | filing |
| 23 Feb 2026filed 23 Feb 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Bought | $15K3,657 at $4.10 | filing |
| 24 Nov 2025filed 25 Nov 2025 | TLSI TriSalus Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 24 Nov 2025filed 25 Nov 2025 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 28 Aug 2025filed 29 Aug 2025 | TLSI TriSalus Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —248,899 at $0.00 | filing |
| 14 Aug 2025filed 15 Aug 2025 | TLSI TriSalus Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —290,000 at $0.00 | filing |
| 14 Aug 2025filed 15 Aug 2025 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 1 Apr 2025filed 2 Apr 2025 | Accelerate Diagnosticsoption or derivative | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 1 Apr 2025filed 2 Apr 2025 | Accelerate Diagnostics | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 1 Apr 2025filed 2 Apr 2025 | Accelerate Diagnostics | SEC FORM 4 Sold | $4,8396,816 at $0.71 | filing |
| 26 Feb 2025filed 27 Feb 2025 | Accelerate Diagnosticsoption or derivative | SEC FORM 4 Code M | —1,500 at $0.00 | filing |
| 26 Feb 2025filed 27 Feb 2025 | Accelerate Diagnostics | SEC FORM 4 Code M | —1,500 at $0.00 | filing |
| 26 Feb 2025filed 27 Feb 2025 | Accelerate Diagnostics | SEC FORM 4 Sold | $583535 at $1.09 | filing |
| 29 May 2024filed 30 May 2024 | Accelerate Diagnosticsoption or derivative | SEC FORM 4 Code A | —120,000 at $0.00 | filing |
| 9 Apr 2024filed 10 Apr 2024 | Accelerate Diagnosticsoption or derivative | SEC FORM 4 Code M | —37,468 at $0.00 | filing |
| 9 Apr 2024filed 10 Apr 2024 | Accelerate Diagnostics | SEC FORM 4 Code M | —37,468 at $0.00 | filing |
News
Reviewing TriSalus Life Sciences (NASDAQ:TLSI) and Brainsway (NASDAQ:BWAY)TLSI · themarketsdaily.com · 21 Oct 2026Financial Comparison: Brainsway (NASDAQ:BWAY) and TriSalus Life Sciences (NASDAQ:TLSI)TLSI · dailypolitical.com · 14 Oct 2026TriSalus Life Sciences, Inc. (TLSI) – What Are Brokerages Saying About This Stock?TLSI · dailypolitical.com · 11 Oct 2026
0 headlines in the last 90 days name David Patience; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.